Intelligence » Amyotrophic Lateral Sclerosis » Last Week

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    Hope for ALS Patients Comes from New Understanding of RNA Metabolism Misregulation

    Monday, March 19, 2018 -- An international team led by neuroscientists at Université de Montréal (UdeM) reports the discovery of a basic molecular mechanism that better helps understand how Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS), works. Their finding may eventually lead to new treatments for the debilitating disease, which cripples people by removing the brain's ability to communicate with their muscles, eventually leading to paralysis and early death, according to the scientists. "It's a story of fundamental research about what happens normally in the body's cells and what changes in the context of ALS," said Jade-Emmanuelle Deshaies, a research associate in neurosciences at the UdeM Hospital Research Centre (CRCHUM) and lead author of the joint Canada–Israel study (“ TDP-43 Regulates the Alternative

    Clinical trial to test efficacy of stem cell transplants in stopping ALS muscle deterioration

    Friday, March 16, 2018 -- Once funding is obtained, researchers can perform a clinical trial to test the efficacy of transplanting bone marrow cells into muscles to stop deterioration caused by the illness. The method has already yielded positive results on mice.

    Coffee and Cannabis; Stephen Hawking’s ALS; New Stroke Risk Loci

    Tuesday, March 20, 2018 -- (MedPage Today) -- News and commentary from the world of neurology and neuroscience